Ghent University Academic Bibliography

Journal Article
A1
open access

Minimal adherence threshold to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation to reduce the risk of thromboembolism and death : a nationwide cohort study

Maxim Grymonprez, Stephane Steurbaut, Andreas Capiau (UGent) , Delphine Vauterin (UGent) , Frauke Van Vaerenbergh (UGent) , Els Mehuys (UGent) , Koen Boussery (UGent) , Tine De Backer (UGent) and Lies Lahousse (UGent)

(2024) CARDIOVASCULAR DRUGS AND THERAPY.

Add to list

Journal Article
A1
open access

Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

Maxim Grymonprez, Andreas Capiau (UGent) , Stephane Steurbaut, Koen Boussery (UGent) , Els Mehuys (UGent) , Annemie Somers (UGent) , Mirko Petrovic (UGent) , Tine De Backer (UGent) and Lies Lahousse (UGent)

(2024) CARDIOVASCULAR DRUGS AND THERAPY.

Add to list

Journal Article
A1
open access

The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Maxim Grymonprez, Mirko Petrovic (UGent) , Tine De Backer (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2024) THROMBOSIS AND HAEMOSTASIS. 124(2). p.135-148

Add to list

Journal Article
A1
open access

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study

Maxim Grymonprez, Tine De Backer (UGent) , Xander Bertels (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.

Add to list

Journal Article
A1
open access

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019 : a nationwide cohort study

Maxim Grymonprez, Tine De Backer (UGent) , Andreas Capiau (UGent) , Delphine Vauterin (UGent) , Els Mehuys (UGent) , Koen Boussery (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2023) BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 89(4). p.1360-1373

Add to list

Journal Article
A1
open access

Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis

Maxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, Tine De Backer (UGent) and Lies Lahousse (UGent)

(2023) CARDIOVASCULAR DRUGS AND THERAPY. 37(4). p.781-791

Add to list

Journal Article
A1
open access

Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

Maxim Grymonprez, Laura Carnoy, Andreas Capiau (UGent) , Koen Boussery (UGent) , Els Mehuys (UGent) , Tine L. De Backer, Stephane Steurbaut and Lies Lahousse (UGent)

(2023) EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 9(8). p.722-730

Add to list

Journal Article
A1
open access

Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation and (morbid) obesity or low body weight : a systematic review and meta-analysis

Maxim Grymonprez, Tine De Backer (UGent) , Stephane Steurbaut, Koen Boussery (UGent) and Lies Lahousse (UGent)

(2022) CARDIOVASCULAR DRUGS AND THERAPY. 36(4). p.749-761

Add to list

Journal Article
A1
open access

Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation : a meta-analysis

Maxim Grymonprez, Kevin Vanspranghe, Andreas Capiau (UGent) , Koen Boussery (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2022) BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 88(7). p.3039-3051

Add to list

Journal Article
A1
open access

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation : a Belgian nationwide cohort study

Maxim Grymonprez, Andreas Capiau (UGent) , Stephane Steurbaut, Els Mehuys (UGent) , Koen Boussery (UGent) , Tine De Backer (UGent) and Lies Lahousse (UGent)

(2022) FRONTIERS IN CARDIOVASCULAR MEDICINE. 9.

Academic Bibliography

Minimal adherence threshold to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation to reduce the risk of thromboembolism and death : a nationwide cohort study

Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019 : a nationwide cohort study

Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis

Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study

Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation and (morbid) obesity or low body weight : a systematic review and meta-analysis

Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation : a meta-analysis

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation : a Belgian nationwide cohort study

Contents

Support

Contact